# A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

> **NCT06941480** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 12 (estimated)

## Conditions studied

- Neuroendocrine Tumor of the Lung
- Neuroendocrine Carcinoma of Lung
- Neuroendocrine Carcinoma
- Neuroendocrine Carcinoma of Prostate

## Interventions

- **DIAGNOSTIC_TEST:** PET/CT
- **BIOLOGICAL:** 177Lu-DTPA-SC16.56

## Key facts

- **NCT ID:** NCT06941480
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2030-05
- **Final completion:** 2030-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06941480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06941480, "A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06941480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*